기본 정보
- 표준 SMILES
CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O- InChIKey
UNFWWIHTNXNPBV-WXKVUWSESA-N- 분자식
- C14H24N2O7
- 평균 분자량
- 332.35 g/mol
- 단동위원소 질량
- 332.15835111
이름 및 식별자
- 우선 이름
- Spectinomycin
- IUPAC
- (1R,3S,5R,8R,10R,11S,12S,13R,14S)-8,12,14-trihydroxy-5-methyl-11,13-bis(methylamino)-2,4,9-trioxatricyclo[8.4.0.03,8]tetradecan-7-one
- 영어명
- Spectinomycin
- 분자식
- C14H24N2O7
- 분자량
- 332.35
이름 및 동의어
이름 더 보기
데이터베이스 식별자
- CAS
1695-77-8、22189-32-8- PubChem CID
- 15541
- DTXSID
DTXSID9023592- ChEMBL
CHEMBL1167- ChEBI
CHEBI:9215- UNII
- 93AKI1U6QF
- EC Number
- 216-911-3、606-950-8
- Nikkaji
- J7.562K
물성
구조 계산 물성
- XLogP
- -3.1
- 극성 표면적
- 130 Ų
- 수소 결합 공여자 수
- 5
- 수소 결합 수용자 수
- 9
- 회전 가능 결합 수
- 2
- 무거운 원자 수
- 23
- 형식 전하
- 0
- 복잡도
- 478
실험 및 물리화학적 성질
LogP
-2.3
-2.3
Solubility
Easily soluble in cold water
1.50e+02 g/L
Collision Cross Section
176.2 Ų [M+H]+ [CCS Type: TW; Method: calibrated with Waters Major Mix];183.5 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with Waters Major Mix]
175.51 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];171.79 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];166.15 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];171.31 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
물리화학적 성질
- 녹는점
- 185 °C · 185 °C (decomp)
- 끓는 점
- 583.1 · 583.1±50.0 °C(Predicted)
- 밀도
- 1.43 · 1.43±0.1 g/cm3(Predicted)
- 저장 조건
- -20 °C · -20°C
- 용해도
- 2 O, · DMSO/H2O, 1:1: soluble 100mg/mL
- 물리적 상태
- solution
- 산도 계수 (pKa)
- 1 · pKa1 6.95, pKa2 8.70(at 25℃)
- 색상
- colorless
- 생물학적 소스
- Streptomyces sp.
- EPA
- Spectinomycin (1695-77-8)
안전 및 규제
GHS 분류
GHS Classification
This chemical does not meet GHS hazard criteria for 5.6% (3 of 54) of reports.
Warning
H315 (90.7%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (92.6%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (92.6%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 54 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 3 of 54 reports by companies.;There are 4 notifications provided by 51 of 54 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
유해성 정보
Hazard Classes and Categories
Skin Irrit. 2 (90.7%);Eye Irrit. 2 (92.6%);STOT SE 3 (92.6%)
Not Classified
독성 정보
규제 정보
안전 데이터
- wgk
- WGK 2
- 스토리지 클래스
- 10 - Combustible liquids
화학 및 산업
약리 정보
ATC Code
J - Antiinfectives for systemic use;J01 - Antibacterials for systemic use;J01X - Other antibacterials;J01XX - Other antibacterials;J01XX04 - Spectinomycin
QJ - Antiinfectives for systemic use;QJ01 - Antibacterials for systemic use;QJ01X - Other antibacterials;QJ01XX - Other antibacterials;QJ01XX04 - Spectinomycin
J01XX04
Pharmacodynamics
Spectinomycin is an aminocyclitol antibiotic produced by a species of soil microorganism designated as S<i>treptomyces spectabilis</i>. In vitro studies have shown spectinomycin to be active against most strains of <i>Neisseria gonorrhoeae</i> (minimum inhibitory concentration <7.5 to 20 mcg/mL). Footprint studies indicate that spectinomycin exerts regional effects on ribosomal structure.
용도 및 제조
Use Classification
Animal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients
Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes
Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes
Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes
Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes
Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes
응용 분야
개요An unusual aminoglycoside antibiotic, spectinomycin is produced by fermentation of Streptomyces spectabil is and differs substantially in its clinical properties from the others. The diaminoinositol unit (spectinamine) contains two mono-N-methyl groups, and the hydroxyl between them has a stereochemistry opposite to that in streptomycin. The glycosidically attached sugar also is unusual in that it contains three consecutive carbonyl groups, either overt or masked, and is fused by two adjacent linkages to spectinamine to produce an unusual, fused, three-ring structure.
용도Spectinomycin finds principal application in the treatment of gonorrhea. It should be noted that the antibiotic resistance among N. gonorrhoeae has caused a number of therapeutic problems. It has been found that only by escalating the antibiotic doses and using probenecid to retard the excretion of penicillin and ampicillin (the drugs of choice) has the continued effective use of penicillin, ampicillin, and tetracycline been possible. Even with modifications in the therapy, from 3 to 8% of cases fail to respond to the usual regimens for uncomplicated gonorrhea. Thus, the treatment of uncomplicated gonorrhea that fails to respond to the usual regimen is spectinomycin therapy.
상·하류 제품 정보
상류 원료
공급사50 곳
추가 설명
정의ChEBI: An organic heterotricyclic antibiotic that is active against gram-negative bacteria and used (as its dihydrochloride pentahydrate) to treat gonorrhea. It is produced by the bacterium Streptomyces spectabilis.
관련 반응
연결된 노트
불러오는 중…